Showing 16,881 - 16,900 results of 100,434 for search '(( 5 we decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.58s Refine Results
  1. 16881

    V2a interneurons subdivisions are differentially distributed along the rostrocaudal axis of the spinal cord. by Cédric Francius (443799)

    Published 2013
    “…<p>(AA″) Immunofluorescence labeling on transverse section at brachial levels of e12.5 embryonic spinal cord shows that V2a interneurons subdivide into medial and lateral groups (arrows). …”
  2. 16882

    Design, Synthesis, and Biological Evaluation of New Peripheral 5HT<sub>2A</sub> Antagonists for Nonalcoholic Fatty Liver Disease by Minhee Kim (1592440)

    Published 2020
    “…Here, structural modifications of pimavanserin (CNS drug), a 5HT<sub>2A</sub> antagonist approved for Parkinson’s disease, led us to synthesize new peripherally acting 5HT<sub>2A</sub> antagonists. …”
  3. 16883
  4. 16884
  5. 16885
  6. 16886
  7. 16887
  8. 16888
  9. 16889

    S5 Fig - by Jérémie Le Pen (18551533)

    Published 2024
    “…(<b>B</b>) Cells as indicated were seeded at similar density, treated or not with Blasticidin (used here as a control to decrease cell viability), and cultured for 4 days before resazurin cell viability assay. …”
  10. 16890
  11. 16891
  12. 16892
  13. 16893

    Drug resistance from preferred antiretroviral regimens for HIV infection in South Africa: A modeling study by Ume L. Abbas (224384)

    Published 2019
    “…Using base case and uncertainty analyses, we assessed (majority) drug resistance levels.</p><p>Results</p><p>By 2030, the median total resistance (proportion of HIV-infected persons with drug resistance) is predicted to reach 31.4% (interquartile range (IQR): 16.5%-50.2%) with CD4-based ART, decreasing to 14.5% (IQR: 7.7%-25.8%) with Fast-track implementation. …”
  14. 16894

    Nitrogen in the defense system of <i>Annona emarginata</i> (Schltdl.) H. Rainer by Felipe Girotto Campos (6808226)

    Published 2019
    “…Plants cultivated with the highest nitrate concentration displaced energy for the reduction of this ion, likely forming nitric oxide, a signaling molecule. This condition, together with the decrease in carbon skeletons, may have contributed to the lower synthesis of volatile substances of the specialized metabolism that are also involved with signaling. …”
  15. 16895

    Data_Sheet_1_When Taekwondo Referees See Red, but It Is an Electronic System That Gives the Points.PDF by Gennaro Apollaro (11828414)

    Published 2021
    “…When it comes to the influence of being a seeded athlete, the results did show a significant confounding effect on the color of the protectors worn by the winner of the match in 2 of 13 weight categories in which a color effect was observed (p = 0.02, C = 0.28; p = 0.02, C = 0.28). …”
  16. 16896
  17. 16897

    Changes of total body weight(A), ovaries(B), uterus(C), vagina and cervix(D), and serum level of FSH(E) and estrogen(F) in treated (Tr) Vs control (Ct) animals at different time po... by Mohsen Ghadami (330178)

    Published 2013
    “…Bone marrow transplanted animals compare to untreated controls showed 40–50% decrease in serum FSH level (E, P<0.03) and 4–5.5 folds increase in serum estrogen (F, P<0.004) at all time points of experiment.…”
  18. 16898

    The SEA induced apoptosis in LX-2 cells in a p53-dependent manner. by Jianxin Wang (35827)

    Published 2014
    “…(B) The LX-2 cells were transfected with si-p53 or scrambled siRNA with or without SEA (10 µg/ml) treatment. The DR5 and cleaved-caspase-3 decreased in the SEA-treated LX-2 cells that were transfected with si-p53 compared to that in the SEA-treated LX-2 cells that were transfected with scrambled siRNA. …”
  19. 16899
  20. 16900

    Antivirals for adult patients hospitalized with SARS-CoV-2 infection: A randomized, Phase II/III, multicenter, placebo-controlled, adaptive study, with multiple arms and stages. CO... by Israel Silva Maia (10438002)

    Published 2022
    “…In conclusion, the REVOLUTIOn trial is designed to provide evidence on whether atazanavir, daclatasvir or sofosbuvir decrease the SARS-CoV-2 load in patients with COVID-19 and increase the number of days patients are free of respiratory support. …”